Pharma industry body urges government to avoid abrupt drug price cuts, backs cancer drug trade margin cap
New Delhi, Nov. 19 -- The Organisation of Pharmaceutical Producers of India (OPPI) on Thursday urged the government to avoid abrupt drug price cuts, saying sudden reductions can disrupt investments made over several years. The industry body backed the government's move to cap trade margins on cancer medicines.
Speaking to ANI on the sidelines of the OPPI Annual Summit 2026 on Pharmaceutical Innovation in New Delhi, OPPI Director General Anil Matai said, "We support the government's initiative for trade margin rationalization." He added, "There should not be abrupt price cuts."
Matai cited the example of drug prices falling by 20 to 40 per cent overnight to explain why research-based drugmakers want greater predictability in pricing, pat...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.